Quick answer: Total testosterone below 400 ng/dL in men produces symptoms of hypogonadism (low libido, fatigue, loss of muscle mass, depression, cognitive decline) but is not the only relevant metric — free testosterone, SHBG, and LH are equally important for understanding the cause and the treatment. Lifestyle factors can raise testosterone by 15–25% before pharmacological intervention is warranted: sleep optimization (30–60% increase with 7–9 hours versus 5 hours), resistance training (12–23% increase with compound movements), zinc and vitamin D repletion (25–40% increase in deficient men), and weight loss (visceral fat produces aromatase that converts testosterone to estrogen). The cause of low testosterone determines the treatment.
Understanding the Testosterone System: Beyond Total T
Testosterone is a steroid hormone produced primarily in the Leydig cells of the testes (95% of production) in response to LH (luteinizing hormone) from the pituitary, which itself is regulated by GnRH (gonadotropin-releasing hormone) from the hypothalamus. The HPT (hypothalamic-pituitary-testicular) axis forms a feedback loop: high testosterone suppresses GnRH and LH; low testosterone stimulates their release. Understanding where in this axis function has broken down determines whether the cause is primary (testicular failure), secondary (pituitary or hypothalamic dysfunction), or functional (inhibited by lifestyle, metabolic, or systemic factors).
The metrics that matter:
Total testosterone: The sum of all forms. Normal range typically 300–1,000 ng/dL in adult men, but “normal” is wide and symptom correlation is more important than absolute number. A 40-year-old at 320 ng/dL with significant symptoms warrants intervention more than a 60-year-old at 310 ng/dL who is asymptomatic.
Free testosterone: Only 2–3% of total testosterone is “free” (unbound to carrier proteins) and biologically active. The rest is bound to SHBG (approximately 44%, tightly bound and metabolically unavailable) and albumin (approximately 54%, loosely bound and partially bioavailable). Free testosterone levels can be low even with normal total testosterone — if SHBG is elevated. Free T below 50 pg/mL in symptomatic men is clinically significant regardless of total testosterone.
SHBG (sex hormone-binding globulin): The primary determinant of free testosterone availability. High SHBG (above 40–50 nmol/L) binds more testosterone, reducing free T even when total T is normal. SHBG is elevated by: aging, liver dysfunction, hyperthyroidism, anorexia, and high-fiber/low-fat diets. SHBG is reduced by: insulin resistance (insulin suppresses SHBG production), obesity, hypothyroidism, elevated androgens, and high-protein diets. Men with metabolic syndrome or insulin resistance often have low SHBG — and their total testosterone appears lower than it is, since free T availability is relatively better than total T alone would suggest.
LH (luteinizing hormone): High LH with low testosterone = primary hypogonadism (testicular failure — testes are not responding to pituitary signal). Low or normal LH with low testosterone = secondary/functional hypogonadism (pituitary or hypothalamic not sending adequate signal, or feedback system is suppressed). This distinction determines treatment: primary hypogonadism typically requires TRT; secondary may be addressable by treating the underlying cause (obesity, sleep apnea, opioid use, hyperprolactinemia, HPA dysregulation).
Estradiol (E2): Men convert testosterone to estradiol via aromatase (expressed in fat tissue). Appropriate estradiol in men (typically 20–30 pg/mL) is necessary for bone health, libido, cardiovascular function, and cognitive function — the notion that estrogen is universally bad for men is incorrect. However, elevated estradiol (above 40–50 pg/mL, often accompanying obesity and visceral fat accumulation) suppresses LH via negative feedback, directly reducing testosterone production, and produces symptoms (gynecomastia, low libido, emotional lability, water retention).
Symptoms of Low Testosterone: The Clinical Picture
The symptoms of testosterone deficiency in men are significant, non-specific (overlapping with thyroid dysfunction, depression, sleep apnea, and metabolic syndrome), and often under-attributed because “normal aging.” They include:
Sexual: Reduced libido (often the first symptom patients report), erectile dysfunction (testosterone is permissive but not sufficient for erections — ED has multiple causes), reduced morning erections, reduced semen volume, and infertility.
Physical: Reduced muscle mass and strength despite training, increased visceral fat (particularly abdominal), reduced bone density (testosterone is anabolic to bone), fatigue, reduced exercise tolerance, and hot flashes (in men with very low testosterone, thermoregulatory dysfunction similar to menopausal hot flashes occurs via the same hypothalamic mechanism).
Psychological and cognitive: Depressed mood, irritability, increased anxiety, reduced motivation and drive (testosterone directly modulates dopaminergic tone in the mesolimbic system), cognitive fog, reduced verbal memory, and difficulty with spatial processing. These symptoms are often attributed to primary depression or dopamine deficiency without evaluating testosterone — creating treatment-resistant depression managed with SSRIs when the underlying driver is hormonal.
Why Testosterone Declines: The Causes
Aging (normal senescent decline): Testosterone declines approximately 1–2% per year after age 30 in most men. By age 70, average total testosterone is approximately 40% of the age-25 peak. This is a normal biological process, not a disease — but in men with additional risk factors, the decline is accelerated and earlier. Functional hypogonadism (low testosterone due to modifiable lifestyle factors) is increasingly common in men in their 30s and 40s and is not simply “early aging.”
Obesity and visceral fat: Visceral fat expresses aromatase at high levels, converting testosterone to estradiol. The resulting estradiol elevation then suppresses LH via negative feedback, further reducing testosterone production. Simultaneously, insulin resistance (which accompanies visceral obesity) reduces SHBG and directly impairs Leydig cell function. This creates a self-reinforcing cycle: low testosterone promotes fat gain and reduces lean mass, fat gain further suppresses testosterone. Weight loss of 10–15% body weight in obese hypogonadal men consistently raises total testosterone by 100–200 ng/dL without any other intervention.
Sleep deprivation and poor sleep quality: The majority of daily testosterone production occurs during sleep, specifically during REM sleep. A 2011 JAMA study found that 1 week of sleep restriction to 5 hours/night reduced testosterone by 10–15% in healthy young men — equivalent to 10–15 years of aging. Sleep apnea is associated with significantly lower testosterone levels regardless of obesity status; treatment of sleep apnea with CPAP raises testosterone. This is one of the most actionable and underaddressed causes of low testosterone in men.
Chronic stress and cortisol: Cortisol and testosterone are antagonistic at multiple levels: cortisol suppresses GnRH release (reducing LH and FSH), directly inhibits Leydig cell testosterone synthesis, and promotes visceral fat accumulation (which aromatizes testosterone to estradiol). The “pregnenolone steal” concept (where chronic stress shifts steroid synthesis toward cortisol at the expense of DHEA and testosterone) is clinically observed, though the mechanisms are more complex than simple substrate competition. The practical implication: stress management is a legitimate testosterone optimization intervention.
Nutritional deficiencies: Several micronutrients are critical for testosterone synthesis: zinc (required for 5α-reductase activity and LH production — zinc deficiency is one of the most documented nutritional causes of hypogonadism and is correctable with supplementation), vitamin D (vitamin D receptor activation in Leydig cells directly regulates testosterone synthesis — men with vitamin D deficiency have significantly lower testosterone), and magnesium (free testosterone correlates significantly with magnesium status — the mechanism involves magnesium’s role in reducing SHBG binding affinity).
Medications: Opioids (suppress GnRH profoundly — opioid-induced androgen deficiency affects 70–90% of men on long-term opioids), statins (may reduce testosterone via impaired cholesterol synthesis — testosterone is derived from cholesterol), SSRIs (reduce libido independently of testosterone, but may also reduce testosterone via serotoninergic suppression of hypothalamic GnRH), finasteride/dutasteride (5α-reductase inhibitors that reduce DHT — a potent androgen — and can cause persistent sexual dysfunction beyond the treatment period), and alcohol (acutely and chronically suppresses testosterone via multiple mechanisms).
The Natural Testosterone Optimization Protocol
Sleep: The Highest-Yield Intervention
Seven to nine hours of quality sleep — specifically preserving REM sleep — is the most impactful single change most men with low testosterone can make. Interventions that specifically increase testosterone via sleep: treating obstructive sleep apnea (CPAP can raise testosterone by 50–100+ ng/dL in men with moderate-severe apnea), achieving consistent sleep timing (circadian regulation of testosterone release is disrupted by irregular schedules), eliminating alcohol before bed (alcohol suppresses REM sleep), and optimizing sleep environment (temperature, darkness, noise). Magnesium glycinate and ashwagandha improve sleep quality through independent mechanisms and both have documented testosterone-supporting effects.
Resistance Training: The Exercise Modality That Matters
Acute testosterone elevation following resistance training is well-established: compound movements (squat, deadlift, bench press, rows) with moderate to heavy loads (75–90% 1RM) and relatively short rest periods (60–90 seconds) produce the highest post-exercise testosterone response. Chronic resistance training increases resting testosterone in men with low baseline levels — the effect is most pronounced in sedentary men becoming active (20–30% increase) and smaller in already-trained individuals (10–15%). Zone 2 aerobic training contributes via visceral fat reduction (reducing aromatase activity) rather than direct testosterone stimulation. Endurance overtraining (excessive volume without adequate recovery) suppresses testosterone — the mechanism is HPA axis overactivation with sustained cortisol elevation.
Dietary Interventions
Several dietary patterns support testosterone synthesis: adequate dietary fat (testosterone is synthesized from cholesterol — very low-fat diets reduce testosterone substrate availability; healthy fats from olive oil, avocados, eggs, and fatty fish support hormonal health), adequate protein (minimum 1.2 g/kg/day to support LH pulsatility and lean mass maintenance), cruciferous vegetables (indole-3-carbinol and DIM support hepatic estrogen clearance, improving the testosterone-to-estradiol ratio without suppressing estradiol to low levels), and avoiding alcohol (which suppresses testosterone via multiple mechanisms and promotes aromatization).
Reducing refined carbohydrates and fructose improves insulin sensitivity, which reduces visceral fat accumulation and the aromatase-driven testosterone suppression that accompanies obesity. Intermittent fasting combined with a whole-food dietary pattern consistently reduces visceral fat and, in overweight men, raises testosterone through the fat loss → reduced aromatase → improved LH pulsatility chain.
Evidence-Based Supplements
Zinc (30 mg/day of zinc bisglycinate or zinc picolinate): The most replicated nutritional intervention for testosterone. Zinc deficiency produces hypogonadism; zinc repletion in deficient men raises testosterone by 74% in one classic study. Even marginally deficient men (serum zinc below 80 mcg/dL) show meaningful testosterone increases with supplementation. Zinc also inhibits aromatase, directly improving the testosterone-to-estradiol ratio. Do not exceed 40 mg/day long-term without monitoring — excess zinc depletes copper.
Vitamin D3 (2,000–5,000 IU/day, targeting serum 25(OH)D 50–80 ng/mL): Vitamin D receptor activation in Leydig cells directly stimulates testosterone synthesis. A 2011 RCT (Pilz et al.) found 3,332 IU/day of vitamin D3 for 12 months raised total testosterone from 10.7 to 13.4 nmol/L (25% increase) in deficient men. Most men in northern latitudes are deficient — testing and replete to optimal levels before assuming the intervention won’t work.
Ashwagandha (KSM-66 or Sensoril, 300–600 mg/day): Multiple RCTs show ashwagandha raises testosterone by 14–22% in men with stress-related hypogonadism — primarily via cortisol reduction (reducing cortisol’s suppression of GnRH and direct Leydig cell inhibition), and possibly via direct stimulation of LH secretion. Also improves sperm quality and motility. The evidence base is solid — it is one of the few “testosterone supplements” with genuine RCT data in actual hypogonadal men rather than just athletic performance models.
Magnesium glycinate (400 mg/day): Magnesium reduces SHBG binding affinity for testosterone, increases free testosterone, and improves sleep quality (which directly increases testosterone production). A study of male athletes found magnesium supplementation raised free testosterone by 24% compared to placebo. Deficiency is common — approximately 50–60% of Americans do not meet the RDA for magnesium.
Fadogia agrestis and Tongkat Ali (LJ100 extract): Among the more interesting emerging supplements. Tongkat Ali (Eurycoma longifolia, LJ100 standardized extract) raises LH and reduces SHBG in several RCTs — producing free testosterone increases of 15–40% in stressed or aging men, with improvements in libido and sexual function. The mechanism appears to involve LH stimulation and SHBG competition. Fadogia agrestis raises LH in animal models but human RCT data is limited; it is typically stacked with Tongkat Ali in sports supplementation. These are not replacements for TRT in clinical hypogonadism but may provide meaningful support in functional deficiency.
When to Consider Testosterone Replacement Therapy
TRT is appropriate when: total testosterone is consistently below 300–350 ng/dL with corroborating symptoms, and lifestyle optimization (sleep, exercise, weight loss, nutritional correction) over 3–6 months has not produced adequate improvement. Primary hypogonadism (high LH, low testosterone) often requires TRT because the testicular failure cannot be addressed by upstream lifestyle change. Secondary hypogonadism due to persistent contributing factors (sleep apnea, obesity, opioids, hyperprolactinemia) should address those factors first, as TRT does not correct the underlying cause and creates exogenous testosterone dependence.
TRT forms include injectable testosterone cypionate or enanthate (most cost-effective, typically biweekly), testosterone gels (topical, daily, more stable levels), testosterone pellets (subcutaneous implant, 3–6 month duration), and buccal/nasal preparations. Each has different pharmacokinetic profiles, convenience tradeoffs, and side effect profiles. Clomiphene citrate (a SERM) and human chorionic gonadotropin (hCG) are alternatives that stimulate endogenous testosterone production rather than replacing it — important for men who wish to preserve fertility, as exogenous testosterone suppresses sperm production via LH suppression. These require physician prescribing and management.
The Bottom Line
Low testosterone in men is not an inevitable consequence of aging — in many cases it is a correctable metabolic and lifestyle problem. The appropriate starting point is comprehensive lab testing (total T, free T, SHBG, LH, FSH, estradiol, prolactin, vitamin D, zinc, full metabolic panel) followed by systematic lifestyle optimization: 7–9 hours of quality sleep, resistance training, visceral fat reduction, zinc and vitamin D repletion, stress management, and addressing any identified secondary causes. This protocol can raise testosterone by 100–300 ng/dL in functional deficiency — often enough to resolve symptoms without pharmacological intervention. When it is not, TRT with appropriate monitoring by a hormone-specialized physician is a reasonable, evidence-based next step.
If you are experiencing symptoms of testosterone deficiency — fatigue, low libido, muscle loss, cognitive fog, or mood changes — a comprehensive hormone panel and metabolic evaluation is the correct starting point. Call our office at (810) 206-1402 to discuss functional hormone optimization as part of a comprehensive men’s health assessment.
Frequently Asked Questions
What is a normal testosterone level for men?
Total testosterone reference range is typically 300–1,000 ng/dL, but “normal” is broad and symptoms matter more than a single number. Optimal functional testosterone for most men is 500–900 ng/dL total, with free testosterone above 50–100 pg/mL. Total testosterone below 400 ng/dL with symptoms warrants investigation and intervention. Always evaluate free testosterone and SHBG alongside total testosterone — total T alone is insufficient because SHBG binds up to 98% of testosterone, making it biologically unavailable.
How do you increase testosterone naturally?
The highest-yield natural interventions: (1) Achieve 7–9 hours of quality sleep — testosterone production occurs primarily during REM sleep; (2) Implement resistance training with compound movements 3x/week; (3) Correct zinc and vitamin D deficiencies (these alone can raise T by 20–40% in deficient men); (4) Reduce visceral fat (each 10% body weight reduction raises testosterone by ~100 ng/dL in obese men); (5) Manage cortisol/stress (consider ashwagandha KSM-66, 300-600 mg/day); (6) Limit alcohol. Combined, these interventions can raise testosterone by 100–300 ng/dL without medication.
At what age does testosterone start declining?
Total testosterone begins declining approximately age 30 at a rate of 1–2% per year in most men. However, this is a population average — many men maintain testosterone well into their 60s and beyond, particularly those with healthy body composition, adequate sleep, and active lifestyles. Free testosterone declines faster because SHBG increases with age, binding more of the available testosterone. Symptoms of deficiency before age 45–50 typically indicate functional hypogonadism (modifiable lifestyle causes) rather than normal aging.
Does testosterone replacement therapy cause infertility?
Yes — exogenous testosterone suppresses LH and FSH (via HPT axis negative feedback), which reduces sperm production. This effect is significant enough that testosterone has been investigated as a male contraceptive. Men wishing to maintain fertility should not use exogenous testosterone. Alternatives that stimulate endogenous production without suppressing sperm: clomiphene citrate (stimulates LH and FSH by blocking estrogen feedback), hCG (mimics LH directly), and enclomiphene. A urologist or reproductive endocrinologist should be consulted for fertility-preserving hormone optimization.
Dive Deeper
- Testosterone Optimization: Why Your Levels Are Declining and How to Reverse It
- Testosterone Optimization in Men: Natural Protocol, Lab Targets, and TRT Guide
- Low Testosterone in Men: Symptoms, Testing, and Natural Protocol
- Testosterone Optimization Naturally: Sleep, Training, Nutrition, and Supplements
- Zone 2 Training: The Science-Backed Exercise for Longevity